The metabolic abnormalities associated with non-alcoholic fatty liver disease

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 5, 2002, Pages 709-731

  Haque, Mahmadul ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty liver; Fatty liver disease; Insulin resistanceSyndrome X; Lipid metabolism; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Oxidant stress; Steatohepatitis

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ALCOHOL CONSUMPTION; DISEASE ASSOCIATION; FATTY LIVER; GLUCONEOGENESIS; HEPATITIS; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LIPID OXIDATION; LIPOLYSIS; MEDICAL LITERATURE; METABOLIC DISORDER; MUSCLE TISSUE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; WESTERN HEMISPHERE; BODY MASS; CARBOHYDRATE METABOLISM; DRUG INHIBITION; LIPID METABOLISM; LIVER INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PHENOTYPE; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; DISEASE COURSE; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGY;

DISEASE PROGRESSION; FATTY LIVER; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 0036783050     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0325     Document Type: Article

References (118)

1. Contos M J Sanyal A J The clinicopathologic spectrum and management of nonalcoholic fatty liver disease Advances in Anatomy and Pathology 9 2002 37-51
2. Bacon B R Farahvash M J Janney C G Neuschwander-Tetri B A Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103-1109
3. Bellentani S Saccoccio G Masutti F et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy Annals of Internal Medicine 132 2000 112-117
4. Sanyal A J Campbell-Sargent C Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183-1192
5. Ludwig J Viggiano T R McGill D B Oh B J Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clinic Proceedings 55 1980 434-438
6. Powell E E Cooksley W G Hanson R et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74-80
7. Wanless I R Lentz J S Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106-1110
8. Ground K EV Prevalence of fatty liver in healthy adults accidentally killed Aviation, Space and Environmental Medicine 55 1984 59-61
9. Marcos A Fisher R A Ham J M et al. Selection and outcome of living donors for adult to adult right lobe transplantation Transplantation 69 2000 2410-2415
10. Garcia Urena M A Colina Ruiz-Delgado F Moreno G E et al. Hepatic steatosis in liver transplant donors: common feature of donor population? World Journal of Surgery 22 1998 837-844
11. Carr A Samaras K Thorisdottir A et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study Lancet 353 1999 2093-2099
12. Miller J Carr A Smith D et al. Lipodystrophy following antiretroviral therapy of primary HIV infection AIDS 14 2000 2406-2407
13. Neuman M G Koren G Tiribelli C In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell line Biochemical and Biophysical Research Communications 197 1993 932-941
14. Britton R S Bacon B R Role of free radicals in liver diseases and hepatic fibrosis Hepatogastroenterology 41 1994 343-348
15. Berson A De B V Letteron P et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 1998 764-774
16. Weltman M D Farrell G C Hall P et al. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis Hepatology 27 1998 128-133
17. Leclercq I A Farrell G C Field J et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis Journal of Clinical Investigation 105 2000 1067-1075
18. Rao M S Reddy J K Peroxisomal beta-oxidation and steatohepatitis Seminars in Liver Disease 21 2001 43-55
19. Diehl A M Cytokine regulation of liver injury and repair Immunological Reviews 174 2000 160-171
20. Himsworth H Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive subtypes Lancet i 1936 127-130
21. Reaven G M Banting Lecture 1988. Role of insulin resistance in human disease 1988 Diabetes 37 1988 1595-1607
22. Patti M E Kahn C R The insulin receptor - a critical link in glucose homeostasis and insulin action Journal of Basic and Clinical Physiology and Pharmacology 9 1998 89-109
23. Kahn C R Baird K L Jarrett D B Flier J S Direct demonstration that receptor crosslinking or aggregation is important in insulin action Proceedings of the National Academy of Sciences of the USA 75 1978 4209-4213
24. Butler A A LeRoith D Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology Endocrinology 142 2001 1685-1688
25. Saltiel A R Kahn C R Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799-806
26. Virkamaki A Ueki K Kahn C R Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance Journal of Clinical Investigation 103 1999 931-943
27. Nakae J Accili D The mechanism of insulin action Journal of Pediatric Endocrinology and Metabolism 12 1999 721-731 (supplement 3)
28. Pessin J E Saltiel A R Signaling pathways in insulin action: molecular targets of insulin resistance Journal of Clinical Investigation 106 2000 165-169
29. Standaert M L Galloway L Karnam P et al. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport Journal of Biological Chemistry 272 1997 30075-30082
30. Alessi D R James S R Downes C P et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr Biol 7(4) 1997 261-269
31. Boulton T G Nye S H Robbins D J et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF Cell 65(4) 1991 663-675
32. Baumann C A Ribon V Kanzaki M et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport Nature 407 2000 202-207
33. Chiang S H Baumann C A Kanzaki M et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10 Nature 410 2001 944-948
34. Watson R T Shigematsu S Chiang S H et al. Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and GLUT4 translocation Journal of Cell Biology 154 2001 829-840
35. Zhang M Chiang J Y Transcriptional regulation of the human sterol 12α-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4α in mediating bile acid repression Journal of Biological Chemistry 276 2001 41690-41699
36. Kahn B B Flier J S Obesity and insulin resistance Journal of Clinical Investigation 106 2000 473-481
37. Nakae J Park B C Accili D Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway Journal of Biological Chemistry 274 1999 15982-15985
38. Shimano H Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes Progress in Lipid Research 40 2001 439-452
39. Shimomura I Matsuda M Hammer R E et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice Molecular Cell 6 2000 77-86
40. Goldstein B J Li P M Ding W et al. Regulation of insulin action by protein tyrosine phosphatases Vitamins and Hormones 54 1998 67-96
41. Anthonsen M W Ronnstrand L Wernstedt C et al. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro Journal of Biological Chemistry 273 1998 215-221
42. Newgard C B Brady M J O'Doherty R M Saltiel A R Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1 Diabetes 49 2000 1967-1977
43. Brady M J Nairn A C Saltiel A R The regulation of glycogen synthase by protein phosphatase 1 in 3T3-L1 adipocytes. Evidence for a potential role for DARPP-32 in insulin action Journal of Biological Chemistry 272 1997 29698-29703
44. Pilkis S J Granner D K Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis Annual Review of Physiology 54 1992 885-909
45. Beale E G Koch S R Brotherton A F et al. Insulin decreases H4IIE cell PEPCK mRNA by a mechanism that does not involve cAMP Diabetes 35 1986 546-549
46. Sutherland C O'Brien R M Granner D K New connections in the regulation of PEPCK gene expression by insulin Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 351 1996 191-199
47. Deng X Cagen L M Wilcox H G et al. Regulation of the rat SREBP-1c promoter in primary rat hepatocytes Biochemical and Biophysical Research Communications 290 2002 256-262
48. Kitamura T Kitamura Y Kuroda S et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt Molecular and Cellular Biology 19 1999 6286-6296
49. Bailey J L Mitch W E Mechanisms of protein degradation: what do the rat studies tell us Journal of Nephrology 13 2000 89-95
50. Araki E Lipes M A Patti M E et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene Nature 372 1994 186-190
51. Griffin M E Marcucci M J Cline G W et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade Diabetes 48 1999 1270-1274
52. Dresner A Laurent D Marcucci M et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity Journal of Clinical Investigation 103 1999 253-259
53. DeFronzo R A Jacot E Jequier E et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization Diabetes 30 1981 1000-1007
54. DeFronzo R A Gunnarsson R Bjorkman O et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus Journal of Clinical Investigation 76 1985 149-155
55. Steppan C M Bailey S T Bhat S et al. The hormone resistin links obesity to diabetes Nature 409 2001 307-312
56. Ferrannini E Vichi S Beck-Nielsen H et al. Insulin action and age Diabetes 45 1996 947-953
57. Hube F Hauner H The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Hormone and Metabolic Research 31 1999 626-631
58. Harris R B Leptin - much more than a satiety signal Annual Review of Nutrition 20 2000 45-75
59. Deslypere J P Verdonck L Vermeulen A Fat tissue: a steroid reservoir and site of steroid metabolism Journal of Clinical Endocrinology and Metabolism 61 1985 564-570
60. Peraldi P Spiegelman B TNF-alpha and insulin resistance: summary and future prospects Molecular and Cellular Biochemistry 182 1998 169-175
61. Roden M Price T B Perseghin G et al. Mechanism of free fatty acid-induced insulin resistance in humans Journal of Clinical Investigation 97 1996 2859-2865
62. Boden G Chen X Ruiz J et al. Mechanisms of fatty acid-induced inhibition of glucose uptake Journal of Clinical Investigation 93 1994 2438-2446
63. Randle P J Garland P B Hales C N Newholme C A The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus Lancet i 1963 785-789
64. Randle P J Priestman D A Mistry S Halsall A Mechanisms modifying glucose oxidation in diabetes mellitus Diabetologia 37 1994 S155-S161
65. Morand C Besson C Demigne C Remesy C Importance of the modulation of glycolysis in the control of lactate metabolism by fatty acids in isolated hepatocytes from fed rats Archives of Biochemistry and Biophysics 309 1994 254-260
66. Warren G B Tipton K F The role of acetyl-CoA in the reaction pathway of pig-liver pyruvate carboxylase European Journal of Biochemistry 47 1974 549-554
67. Masuzaki H Paterson J Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome Science 294 2001 2166-2170
68. Tomlinson J W Stewart P M Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase Baillière's Best Practice and Research Clinical Endocrinology and Metabolism 15 2001 61-78
69. Tomlinson J W Bujalska I Stewart P M Cooper M S The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis Endocrine Research 26 2000 711-722
70. Bergman R N New concepts in extracellular signaling for insulin action: the single gateway hypothesis Recent Progress in Hormone Research 52 1997 359-385
71. Gulick T Cresci S Caira T et al. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression Proceedings of the National Academy of Sciences of the USA 91 1994 11012-11016
72. Prentki M Corkey B E Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45 1996 273-283
73. Hardardottir I Kunitake S T Moser A H et al. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters Journal of Clinical Investigation 94 1994 1304-1309
74. Hotamisligil G S The role of TNFalpha and TNF receptors in obesity and insulin resistance Journal of Internal Medicine 245 1999 621-625
75. Muoio D M Dohm G L Fiedorek F T Jr. et al. Leptin directly alters lipid partitioning in skeletal muscle Diabetes 46 1997 1360-1363
76. Campfield L A Smith F J Guisez Y et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks Science 269 1995 546-549
77. Halaas J L Gajiwala K S Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 1995 543-546
78. Yamauchi T Kamon J Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nature Medicine 7 2001 941-946
79. Steppan C M Brown E J Wright C M et al. A family of tissue-specific resistin-like molecules Proceedings of the National Academy of Sciences of the USA 98 2001 502-506
80. DeFronzo R A Tobin J D Andres R Glucose clamp technique: a method for quantifying insulin secretion and resistance American Journal of Physiology 237 1979 E214-E223
81. Matthews D R Hosker J P Rudenski A S et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412-419
82. Katz A Nambi S S Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans Journal of Clinical Endocrinology and Metabolism 85 2000 2402-2410
83. Olefsky J Farquhar J W Reaven G Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects Diabetes 22 1973 507-513
84. Matsuda M DeFronzo R A Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462-1470
85. Galvin P Ward G Walters J et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test Diabetic Medicine 9 1992 921-928
86. Bergman R N Ider Y Z Bowden C R Cobelli C Quantitative estimation of insulin sensitivity American Journal of Physiology 236 1979 E667-E677
87. Bogardus C Lillioja S Howard B V et al. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects Journal of Clinical Investigation 74 1984 1238-1246
88. Hollenbeck C Reaven G M Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance Journal of Clinical Endocrinology and Metabolism 64 1987 1169-1173
89. Krook A O'Rahilly S Mutant insulin receptors in syndromes of insulin resistance Baillière's Clinical Endocrinology and Metabolism 10 1996 97-122
90. Swislocki A L Chen Y D Golay A et al. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes Diabetologia 30 1987 622-626
91. Kissebah A H Krakower G R Regional adiposity and morbidity Physiological Reviews 74 1994 761-811
92. Reaven G Miller R Study of the relationship between glucose and insulin responses to an oral glucose load in man Diabetes 17 1968 560-569
93. Magre J Delepine M Khallouf E et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13 Nature Genetics 28 2001 365-370
94. Garg A Wilson R Barnes R et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34 Journal of Clinical Endocrinology and Metabolism 84 1999 3390-3394
95. Shimomura I Hammer R E Ikemoto S et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 1999 73-76
96. Estrada V Serrano-Rios M Larrad M T et al. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy Journal of Acquired Immune Deficiency Syndrome 29 2002 32-40
97. Carr A Samaras K Chisholm D J Cooper D A Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance Lancet 351 1998 1881-1883
98. Walli R Michl G M Muhlbayer D et al. Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus Research in Experimental Medicine 199 2000 253-262
99. Caldwell S H Swerdlow R H Khan E M et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis Journal of Hepatology 31 1999 430-434
100. Cossarizza A Mussini C Vigano A Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays 23 2001 1070-1080
101. Lancaster J R Jr. Laster S M Gooding L R Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor FEBS Letters 248 1989 169-174
102. Pessayre D Mansouri A Haouzi D Fromenty B Hepatotoxicity due to mitochondrial dysfunction Cell Biology and Toxicology 15 1999 367-373
103. Pierce R H Campbell J S Stephenson A B et al. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line American Journal of Pathology 157 2000 221-236
104. Hruszkewycz A M Evidence for mitochondrial DNA damage by lipid peroxidation Biochemical and Biophysical Research Communications 153 1988 191-197
105. Chen J Schenker S Frosto T A Henderson G I Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits Biochimica Biophysica Acta 1380 1998 336-344
106. Chinetti G Fruchart J C Staels B Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflammation Research 49 2000 497-505
107. De Craemer D Pauwels M Van den B C Alterations of peroxisomes in steatosis of the human liver: a quantitative study Hepatology 22 1995 744-752
108. Chitturi S Abeygunasekera S Farrell G C et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373-379
109. Robertson G Leclercq I Farrell G C Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress American Journal of Physiology. Gastrointestinal and Liver Physiology 281 2001 G1135-G1139
110. Fraze E Donner C C Swislocki A L et al. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance Journal of Clinical Endocrinology and Metabolism 61 1985 807-811
111. Clement S Krause U Desmedt F et al. The lipid phosphatase SHIP2 controls insulin sensitivity Nature 409 2001 92-97
112. Cho H Mu J Kim J K et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science 292 2001 1728-1731
113. Elchebly M Payette P Michaliszyn E et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 283 1999 1544-1548
114. Withers D J Gutierrez J S Towery H et al. Disruption of IRS-2 causes type 2 diabetes in mice Nature 391 1998 900-904
115. Kadowaki T Tamemoto H Tobe K et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 and identification of insulin receptor substrate-2 Diabetic Medicine 13 1996 S103-S108
116. Katz E B Stenbit A E Hatton K et al. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4 Nature 377 1995 151-155
117. Fruman D A Mauvais-Jarvis F Pollard D A et al. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha Nature Genetics 26 2000 379-382
118. Pillay T S Xiao S Olefsky J Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites Journal of Clinical Investigation 97 1996 613-620